Trials / Terminated
TerminatedNCT02431663
Ketamine in Refractory Convulsive Status Epilepticus
Efficacy of Ketamine in Refractory Convulsive Status Epilepticus in Children: a Multicenter, Randomized, Controlled, Open-label, No-profit, With Sequential Design Study.
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Meyer Children's Hospital IRCCS · Academic / Other
- Sex
- All
- Age
- 1 Month – 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of intravenous administration of ketamine in the treatment of refractory convulsive status epilepticus in children compared to administration of midazolam at high doses, thiopental and / or propofol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | Intravenous administration in continuous |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2020-03-31
- Completion
- 2020-03-31
- First posted
- 2015-05-01
- Last updated
- 2020-10-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02431663. Inclusion in this directory is not an endorsement.